BNTX
$110.88
Revenue | $260.8Mn |
Net Profits | $-386.6Mn |
Net Profit Margins | -148.24% |
Biontech Se’s revenue jumped 101.62% since last year same period to $260.8Mn in the Q2 2025. On a quarterly growth basis, Biontech Se has generated 42.67% jump in its revenue since last 3-months.
Biontech Se’s net profit jumped 52.38% since last year same period to $-386.6Mn in the Q2 2025. On a quarterly growth basis, Biontech Se has generated 7.02% jump in its net profits since last 3-months.
Biontech Se’s net profit margin jumped 76.38% since last year same period to -148.24% in the Q2 2025. On a quarterly growth basis, Biontech Se has generated 34.83% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.99 |
EPS Estimate Current Year | -0.99 |
Biontech Se’s earning per share (EPS) estimates for the current quarter stand at -0.99 - a 29.88% jump from last quarter’s estimates.
Biontech Se’s earning per share (EPS) estimates for the current year stand at -0.99.
Earning Per Share (EPS) | 0 |
Biontech Se’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Biontech Se has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-11-03 | -0.99 | 0 | 100% |
2025-05-05 | -2.35 | -1.82 | 22.42% |
2025-08-04 | -1.41 | -1.6 | -13.48% |